Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin:Cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1811, Issue 12, 2011, Pages 1115-1123

  Ohnsorg, Pascale M ^a,b   Mary, Jean Luc ^c   Rohrer, Lucia ^a,b   Pech, Michael ^c   Fingerle, Jürgen ^c   Von Eckardstein, Arnold ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Preclinical Research   (Switzerland)

Author keywords

ABCA1; Cholesterol efflux; Endothelium; High density lipoprotein; Reverse cholesterol transport; Transcytosis

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; PALMITOYL 2 OLEYL PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SMALL INTERFERING RNA; TRIMERIZED APOLIPOPROTEIN A I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CELL KINETICS; CONCENTRATION (PARAMETERS); COW; ENDOTHELIUM CELL; ENZYME RECONSTITUTION; FOAM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID TRANSPORT; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT;

ANIMALS; AORTA; APOLIPOPROTEIN A-I; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CARDIOVASCULAR AGENTS; CATTLE; CORONARY DISEASE; ENDOTHELIAL CELLS; GENE SILENCING; HUMANS; KINETICS; LIPOPROTEINS, HDL; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHATIDYLCHOLINES; PROTEIN BINDING; PROTEIN TRANSPORT; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING;

EID: 80355132735     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.09.001     Document Type: Article

References (54)

1. C.P. Cannon, B.A. Steinberg, S.A. Murphy, J.L. Mega, and E. Braunwald Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J. Am. Coll. Cardiol. 48 2006 438 445 (Pubitemid 44109954)
2. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
3. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, and A.M. Skene Intensive versus moderate lipid lowering with statins after acute coronary syndromes N. Engl. J. Med. 350 2004 1495 1504 (Pubitemid 38477774)
4. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, and N.K. Wenger Intensive lipid lowering with atorvastatin in patients with stable coronary disease N. Engl. J. Med. 352 2005 1425 1435 (Pubitemid 40471450)
5. S. Lewington, G. Whitlock, R. Clarke, P. Sherliker, J. Emberson, J. Halsey, N. Qizilbash, R. Peto, and R. Collins Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 370 2007 1829 1839
6. I. Bolibar, A. von Eckardstein, G. Assmann, and S. Thompson Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities Thromb. Haemost. 84 2000 955 960
7. P. Barter, A.M. Gotto, J.C. LaRosa, J. Maroni, M. Szarek, S.M. Grundy, J.J. Kastelein, V. Bittner, and J.C. Fruchart HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events N. Engl. J. Med. 357 2007 1301 1310 (Pubitemid 47481452)
8. E.M. deGoma, N.J. Leeper, and P.A. Heidenreich Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol J. Am. Coll. Cardiol. 51 2008 49 55
9. A. von Eckardstein, J.R. Nofer, and G. Assmann High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport Arterioscler. Thromb. Vasc. Biol. 21 2001 13 27 (Pubitemid 32061923)
10. A.S. Plump, C.J. Scott, and J.L. Breslow Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse Proc. Natl. Acad. Sci. U.S.A. 91 1994 9607 9611 (Pubitemid 24297964)
11. R.K. Tangirala, K. Tsukamoto, S.H. Chun, D. Usher, E. Pure, and D.J. Rader Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice Circulation 100 1999 1816 1822 (Pubitemid 29498389)
12. S. Patel, B.A. Di Bartolo, S. Nakhla, A.K. Heather, T.W. Mitchell, W. Jessup, D.S. Celermajer, P.J. Barter, and K.A. Rye Anti-inflammatory effects of apolipoprotein A-I in the rabbit Atherosclerosis 212 2010 392 397
13. E.M. Rubin, R.M. Krauss, E.A. Spangler, J.G. Verstuyft, and S.M. Clift Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 1991 265 267 (Pubitemid 21896769)
14. T. Joy, and R.A. Hegele Is raising HDL a futile strategy for atheroprotection? Nat. Rev. Drug Discov. 7 2008 143 155 (Pubitemid 351194062)
15. D. Duffy, and D.J. Rader Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport Circulation 113 2006 1140 1150
16. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, M. Yasin, G.M. Eaton, M.A. Lauer, W.S. Sheldon, C.L. Grines, S. Halpern, T. Crowe, J.C. Blankenship, and R. Kerensky Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300 (Pubitemid 37430562)
17. J.A. Shaw, A. Bobik, A. Murphy, P. Kanellakis, P. Blombery, N. Mukhamedova, K. Woollard, S. Lyon, D. Sviridov, and A.M. Dart Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque Circ. Res. 103 2008 1084 1091
18. J.C. Tardif, J. Gregoire, P.L. L'Allier, R. Ibrahim, J. Lesperance, T.M. Heinonen, S. Kouz, C. Berry, R. Basser, M.A. Lavoie, M.C. Guertin, and J. Rodes-Cabau Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial JAMA 297 2007 1675 1682 (Pubitemid 46631626)
19. E.A. Brinton, S. Eisenberg, and J.L. Breslow Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution Arterioscler. Thromb. 14 1994 707 720
20. A.J. Mendez The promise of apolipoprotein A-I mimetics Curr. Opin. Endocrinol. Diabetes Obes. 17 2010 171 176
21. J.H. Graversen, J.M. Laurberg, M.H. Andersen, E. Falk, J. Nieland, J. Christensen, M. Etzerodt, H.C. Thogersen, and S.K. Moestrup Trimerization of apolipoprotein A-I retards plasma clearance and preserves antiatherosclerotic properties J. Cardiovasc. Pharmacol. 51 2008 170 177 (Pubitemid 351301478)
22. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 263 2008 256 273 (Pubitemid 351207349)
23. C. Cavelier, I. Lorenzi, L. Rohrer, and A. von Eckardstein Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1 Biochim. Biophys. Acta 1761 2006 655 666 (Pubitemid 44108746)
24. W. Jessup, I.C. Gelissen, K. Gaus, and L. Kritharides Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages Curr. Opin. Lipidol. 17 2006 247 257 (Pubitemid 43786058)
25. I. Lorenzi, A. von Eckardstein, S. Radosavljevic, and L. Rohrer Lipidation of apolipoprotein A-I by ATP-binding cassette transporter (ABC) A1 generates an interaction partner for ABCG1 but not for scavenger receptor BI Biochim. Biophys. Acta 1781 2008 306 313
26. X. Rousset, B. Vaisman, M. Amar, A.A. Sethi, and A.T. Remaley Lecithin: cholesterol acyltransferase-from biochemistry to role in cardiovascular disease Curr. Opin. Endocrinol. Diabetes Obes. 16 2009 163 171
27. A. von Eckardstein, and L. Rohrer Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins Curr. Opin. Lipidol. 20 2009 197 205
28. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
29. A. von Eckardstein, H. Funke, M. Walter, K. Altland, A. Benninghoven, and G. Assmann Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure J. Biol. Chem. 265 1990 8610 8617
30. K.H. Cho, D.M. Durbin, and A. Jonas Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements J. Lipid Res. 42 2001 379 389 (Pubitemid 32270062)
31. M. Tufteland, J.B. Pesavento, R.L. Bermingham, P.D. Hoeprich Jr., and R.O. Ryan Peptide stabilized amphotericin B nanodisks Peptides 28 2007 741 746 (Pubitemid 46349336)
32. A. Jonas, A. von Eckardstein, K.E. Kezdy, A. Steinmetz, and G. Assmann Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants J. Lipid Res. 32 1991 97 106
33. J.R. Nofer, B. Levkau, I. Wolinska, R. Junker, M. Fobker, A. von Eckardstein, U. Seedorf, and G. Assmann Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids J. Biol. Chem. 276 2001 34480 34485
34. C.M. Gajdusek, and S.M. Schwartz Technique for cloning bovine aortic endothelial cells In Vitro 19 1983 394 402 (Pubitemid 15218448)
35. W.S. Davidson, K.L. Gillotte, S. Lund-Katz, W.J. Johnson, G.H. Rothblat, and M.C. Phillips The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol J. Biol. Chem. 270 1995 5882 5890
36. L. Rohrer, C. Cavelier, S. Fuchs, M.A. Schluter, W. Volker, and A. von Eckardstein Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells Biochim. Biophys. Acta 1761 2006 186 194
37. L. Rohrer, P.M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. von Eckardstein High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1 Circ. Res. 104 2009 1142 1150
38. C. Cavelier, L. Rohrer, and A. von Eckardstein ATP-Binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells Circ. Res. 99 2006 1060 1066 (Pubitemid 44729929)
39. P.M. Ohnsorg, L. Rohrer, D. Perisa, A. Kateifides, A. Chroni, D. Kardassis, V.I. Zannis, and A. von Eckardstein Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells J. Biol. Chem. 286 2011 7744 7754
40. A. von Eckardstein Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target? Expert Rev. Cardiovasc. Ther. 8 2010 345 358
41. T.X. Pedersen, S. Bro, M.H. Andersen, M. Etzerodt, M. Jauhiainen, S. Moestrup, and L.B. Nielsen Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice Atherosclerosis 202 2009 372 381
42. L. Calabresi, G. Vecchio, F. Frigerio, L. Vavassori, C.R. Sirtori, and G. Franceschini Reconstituted high-density lipoproteins with a disulfide-linked apolipoprotein A-I dimer: evidence for restricted particle size heterogeneity Biochemistry 36 1997 12428 12433 (Pubitemid 27446665)
43. J.K. Bielicki, M.R. McCall, L.J. Stoltzfus, A. Ravandi, A. Kuksis, E.M. Rubin, and T.M. Forte Evidence that apolipoprotein A-IMilano has reduced capacity, compared with wild-type apolipoprotein A-I, to recruit membrane cholesterol Arterioscler. Thromb. Vasc. Biol. 17 1997 1637 1643 (Pubitemid 27423980)
44. L. Calabresi, G. Franceschini, A. Burkybile, and A. Jonas Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer Biochem. Biophys. Res. Commun. 232 1997 345 349 (Pubitemid 27216216)
45. L. Calabresi, M. Canavesi, F. Bernini, and G. Franceschini Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer Biochemistry 38 1999 16307 16314 (Pubitemid 129520553)
46. X. Zhu, G. Wu, W. Zeng, H. Xue, and B. Chen Cysteine mutants of human apolipoprotein A-I: a study of secondary structural and functional properties J. Lipid Res. 46 2005 1303 1311 (Pubitemid 43109845)
47. G.L. Weibel, E.T. Alexander, M.R. Joshi, D.J. Rader, S. Lund-Katz, M.C. Phillips, and G.H. Rothblat Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux Arterioscler. Thromb. Vasc. Biol. 27 2007 2022 2029 (Pubitemid 47312313)
48. 13C NMR studies of lysine ionization behavior J. Biol. Chem. 267 1992 25830 25838 (Pubitemid 23013985)
49. A. Jonas, N.L. Zorich, K.E. Kezdy, and W.E. Trick Reaction of discoidal complexes of apolipoprotein A-I and various phosphatidylcholines with lecithin cholesterol acyltransferase. Interfacial effects J. Biol. Chem. 262 1987 3969 3974
50. A. Jonas, S.A. Sweeny, and P.N. Herbert Discoidal complexes of A and C apolipoproteins with lipids and their reactions with lecithin: cholesterol acyltransferase J. Biol. Chem. 259 1984 6369 6375 (Pubitemid 14108182)
51. K.E. Kypreos, and V.I. Zannis Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT Biochem. J. 403 2007 359 367 (Pubitemid 46596593)
52. Y. Feng, M. van Eck, E. Van Craeyveld, F. Jacobs, V. Carlier, S. Van Linthout, M. Erdel, M. Tjwa, and B. De Geest Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer Blood 113 2009 755 764
53. D. Seetharam, C. Mineo, A.K. Gormley, L.L. Gibson, W. Vongpatanasin, K.L. Chambliss, L.D. Hahner, M.L. Cummings, R.L. Kitchens, Y.L. Marcel, D.J. Rader, and P.W. Shaul High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I Circ. Res. 98 2006 63 72 (Pubitemid 43970204)
54. C. Tso, G. Martinic, W.H. Fan, C. Rogers, K.A. Rye, and P.J. Barter High-density lipoproteins enhance progenitor-mediated endothelium repair in mice Arterioscler. Thromb. Vasc. Biol. 26 2006 1144 1149 (Pubitemid 43732125)